Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

JCI online early table of contents: Dec. 6, 2010

December 6, 2010 10:36 am | by EurekAlert | News | Comments

(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Dec. 6, 2010, in the JCI: "Alpha-2 integrin: a protein predictor of tumor spread?;" "A DEDD cert to support embryo...

TOPICS:

NaviNet buys mobile health IT firm Prematics

December 6, 2010 10:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Health information technology firm NaviNet has bought Prematics Inc, a provider of mobile health IT solutions for doctors. Cambridge-based NaviNet said the acquisition of Virginia-based Prematics would enable the company to extend its services to physicians using handheld devices.

Researchers create new high-performance fiber

December 6, 2010 10:35 am | by I-Micronews | News | Comments

Researchers at Northwestern University have nanoengineered a new kind of fiber that could be tougher than Kevlar.

Advertisement

Ventas wraps $186M deal for senior housing assets

December 6, 2010 8:45 am | by The Associated Press | News | Comments

Real estate investment trust Ventas Inc. said Monday it has completed a $186 million buyout of 58 senior housing communities from affiliates of Sunrise Senior Living Inc.Ventas initially had between 15 percent and 25 percent ownership in the communities. The deal gives Ventas full ownership in...

A DEDD cert to support embryo development

December 6, 2010 8:36 am | by EurekAlert | News | Comments

(Journal of Clinical Investigation) Before the placenta is established, a structure that is key to supporting embryonic development forms in the uterus. Defective formation of this structure is thought to be a cause of female infertility. Researchers have now determined that the...

TOPICS:

Health care reform still divisive

December 6, 2010 8:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

While 40 percent of Americans want to repeal all or most of last year's health care reform bill, 31 percent want all or most of the reforms. In a Harris Interactive Poll conducted in partnership with Norwalk, Conn.-based HealthDay, the results indicate that people across the nation remain...

FDA grants study of Abiomed heart device

December 6, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cardiac medical device maker Abiomed Inc. has won conditional approval from the U.S. Food and Drug Administration for a pilot study to test its Impella 2.5 device reducing heart muscle damage in patients with ST-elevation myocardial infarction (STEMI).

ArQule begins trial of cancer drug candidate

December 6, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

ArQule Inc. has enrolled its first patient in a Phase 1 clinical trial aimed at testing ARQ 736, its small molecule inhibitor of the RAF kinases, ArQule officials announced today in a press release.

Advertisement

KLS Martin's SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Dec. 6, 2010 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, US craniomaxillofacial plate and screw market growth will be driven by uptake of new resorbable polymers and novel implantation techniques. KLS Martin's...

TOPICS:

diaDexus to Present at the Canaccord Genuity Healthcare Conference

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2010 /- diaDexus, Inc. (OTC Bulletin Board: DDXS ), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to...

TOPICS:

CTCs Predict Poor Outcome From Blood Stem Cell Transplantation Therapy for Metastatic Breast Cancer

December 6, 2010 7:34 am | by AACR | News | Comments

• High-dose chemotherapy and autologous stem cell transplantation is effective therapy. • Therapy may release cancer stem-like cells from bone marrow. • Patients who had low circulating tumor cells did well. SAN ANTONIO - Metastatic breast cancer patients who had circulating tumor cells...

TOPICS:

In the Treatment of COPD, Greater Use in the Primary Care Setting Will Strengthen Spiriva's Position Among Sales Leaders

December 6, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 6, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim/Pfizer's Spiriva will most likely strengthen its position among the sales leaders for the treatment of...

TOPICS:

Compumedics Home Sleep Testing System Selected for Use in US National Institute of Health (NIH)-Sponsored Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study

December 6, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

CHARLOTTE, N.C., Dec. 6, 2010 /- Compumedics USA, Inc. (CMP.ASX) today announced its new Somte® PSG portable sleep-testing systems were chosen as part of a major new study to further investigate the link between sleep disorders and cardio-vascular disease in various ethnic and racial...

TOPICS:

All-In-One Mid-Power Green Q-Switched DPSS Laser

December 6, 2010 6:35 am | Product Releases | Comments

Spectra-Physics announces the world’s first, 5 Watt, all-in-one green Q-switched diode-pumped solid-state (DPSS) laser that combines the laser head and electronics into a single, compact package that fits in the palm of your hand.

JAK inhibitors producing significant response in myelofibrosis patients

December 6, 2010 6:34 am | by EurekAlert | News | Comments

(Mayo Clinic) Two janus kinase inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology Dec. 4 in Orlando.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading